NEW YORK (GenomeWeb News) – Bruker BioSciences said today that the Hart-Scott-Rodino waiting period for its proposed acquisition of affiliate Bruker BioSpin has expired.
 
Bruker BioSciences announced in early December that it had launched a $914 million takeover of Bruker BioSpin, which is 100 percent owned by members of the Laukien family, who also own 52 percent of publicly traded Bruker BioSciences.
 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Rare gene mutations are guiding the search for drugs to manage chronic pain without opioids, according to CNBC.

The new Francis Crick Institute building can get too noisy for some researchers to concentrate, according to the Guardian.

CBS News reports that there are still many vacancies at the White House Office of Science and Technology Policy, but that it's uncertain whether they will be filled.

In Nucleic Acids Research this week: pipeline to analyze and visualize bacterial genomes, database of global set of human genomes, and more.